Corient Private Wealth
BIIB icon

Corient Private Wealth’s Biogen BIIB Stock Holding History

Corient Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
48,315
+11,363
+31% +$2.17M 0.01% 642
2026
Q1 		$6.75M Sell
36,952
-50,515
-58% -$9.31M 0.01% 750
2025
Q4 		$13.9M Buy
87,467
+52,605
+151% +$8.59M 0.01% 668
2025
Q3 		$4.88M Buy
34,862
+531
+2% +$71.8K 0.01% 722
2025
Q2 		$4.31M Buy
34,331
+4,540
+15% +$566K 0.01% 743
2025
Q1 		$4.08M Buy
29,791
+407
+1% +$58.2K 0.01% 741
2024
Q4 		$4.49M Sell
29,384
-338
-1% -$57K 0.01% 737
2024
Q3 		$5.76M Sell
29,722
-3,100
-9% -$649K 0.01% 712
2024
Q2 		$7.61M Buy
32,822
+2,474
+8% +$538K 0.01% 593
2024
Q1 		$6.54M Sell
30,348
-864
-3% -$202K 0.01% 634
2023
Q4 		$8.08M Buy
31,212
+8,453
+37% +$2.08M 0.01% 572
2023
Q3 		$5.85M Buy
22,759
+642
+3% +$172K 0.01% 606
2023
Q2 		$6.3M Buy
22,117
+265
+1% +$78.9K 0.01% 569
2023
Q1 		$6.08M Buy
21,852
+7,602
+53% +$2.1M 0.02% 540
2022
Q4 		$3.94M Buy
+14,250
New +$4.02M 0.01% 550

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corient Private Wealth's BIIB Position: Q2 2026 in Review

Corient Private Wealth increased its Biogen (BIIB) stake by 31% in Q2 2026, buying an estimated $2.17M and bringing the position to 48,315 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #642.

Corient Private Wealth first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.9M in Q4 2025. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Corient Private Wealth held 48,315 shares of Biogen worth $10.6M as of Q2 2026.
  • Corient Private Wealth bought 11,363 Biogen shares in Q2 2026, an estimated $2.17M.
  • Biogen made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #642 holding.
  • Corient Private Wealth first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Biogen position peaked at $13.9M in Q4 2025.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.